Surgical Site Infiltration Using Ketamine Versus Bupivacaine for Analgesia in Post-operative Appendectomy Operation

Sponsor
Sohag University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05097118
Collaborator
(none)
60
1
2
5
11.9

Study Details

Study Description

Brief Summary

surgical site infiltration using ketamine versus Bupivacaine for analgesia in post-operative Appendectomy operation by Ketamine versus Bupivacaine

Condition or Disease Intervention/Treatment Phase
  • Drug: Ketamine Versus Bupivacaine
Early Phase 1

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Surgical Site Infiltration Using Ketamine Versus Bupivacaine for Analgesia in Post-operative Appendectomy Operation
Actual Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Feb 1, 2022
Anticipated Study Completion Date :
Feb 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group of Ketamine injection

Ketamine infiltration for post operative analgesia

Drug: Ketamine Versus Bupivacaine
Drugs Ketamine versus Bupivacaine

Experimental: Group of Bupivacaine injection

Bupivacaine infiltration for post operative analgesia

Drug: Ketamine Versus Bupivacaine
Drugs Ketamine versus Bupivacaine

Outcome Measures

Primary Outcome Measures

  1. Comparison study between Ketamine and Bupivacaine for post operative analgesia [one year]

    Analgesia for post -operative Appendectomy operation

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 60 adult patients with ASA physical physical status class 1 and class 2 undergoing uncomplicated appendectomy under general anesthesia
Exclusion Criteria:
  • Patient refusal

  • drug abuse

  • Patient with neurological, psychiatirc or neuromuscular disease

  • chronic pain on medicine

  • known allergy to the study medicine

  • Infection at the site of infiltration

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sohag University Hospital Sohag Egypt

Sponsors and Collaborators

  • Sohag University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Gehad Ahmed Aly, resident doctor at Anaesthesia and ICU department sohag university hospital, Sohag University
ClinicalTrials.gov Identifier:
NCT05097118
Other Study ID Numbers:
  • Soh-Med-21-10-03
First Posted:
Oct 27, 2021
Last Update Posted:
Nov 5, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 5, 2021